Thursday, August 11, 2022

“Personalize and Tailor” Veins, Learn About the Achievements of This Clinical Trial

Using tissue engineering techniques, a healthy vein from a deceased donor patient is used.

Dr. Andres García León, Head of the Angiology and Vascular Surgery Service at Valme Hospital in Seville. Photo: Courtesy of MedicalWriting.

The project is a network between multiple hospitals and the teams involved in performing venous transplantation as clinical trials develop in patients where the collaboration of a multidisciplinary team is required: ranging from clinical professionals. To experts in technology and regulation.

This was reported by Andrés García León, Head of the Angiology and Vascular Surgery Service at Valme Hospital in Seville and coordinator of the world’s leading study and milestone for Andalusian public health on the implantation of venous segments.

Through tissue engineering techniques, “we take a healthy vein from a deceased donor patient, which is usually of no use for other types of reconstruction” and the cell from said donor is eliminated from the bioreactor. Next, “we decellularized Vein healthy” and when we have a recipient, we do a peripheral blood extraction, “like when blood is donated”, and with it reinserted into the bioreactor.” That is, one would always be made of cells. That is, we transform a foreign vein into one,” Garcia explains.

Read Also:  Estrogen increases your chances of developing migraines, Dr. Fiorito notes

In addition, after the holiday, prescribed two or three days after the intervention, Patient An anticoagulant treatment regimen for one year, during which implant functionality is checked, and where a follow-up is done to check Viability of this vascular segment that has been implanted.

How are suitable patients identified?

Candidate patients are patients who come here Angiology and Vascular surgery consultation and, via an ultrasound, a femoral vein disease And they are diagnosed with one, they are diagnosed with deep venous insufficiency. “Later, you have to cancel a range of risk factors To be able to do the operation”, says the doctor.

The trial, which is currently in Phase I in Spain, has already conducted its first intervention at the Virgen de las Nieves Hospital, a collaborative research centre, after receiving authorization from the Medicines and Health Products Agency in December 2020. The full study will include 14 more patients aged 18 to 75 with venous insufficiency chronic venous system Deep.

Read Also:  Omicron: Vaccines are the best defense against this COVID-19 variant and others

This therapy, according to García León, “offers a guarantee of future success”, as “to date the only therapeutic route that could be offered to these patients was for a lifetime. elastic compression stockings Strong or unsuccessful attempts at surgical reconstruction of diseased vein valves,

Source consulted here.

Nation World News Desk
Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -